Watch MLAB. Know when insiders buy.
One email the day a filing lands. Free.
MLAB
MESA LABORATORIES INC /CO/
126.54
−0.60 −0.47%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $708.1MP/E 148.9DIV YIELD —FCF YIELD 7.47%REV TTM $249.7M +3.0%NET INCOME $4.8MNET DEBT $35.4M52W 64.07 – 130.65SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | $60.1M | +1.0% | 64.9% | $7M | $2.8M | −40.3% | 0.49 | $14.7M | $559K | $14.2M | Aug 10 |
| Q4 2026 · Mar 31derived | $63.7M | +2.6% | 66.2% | $2.7M | −$4.1M | — | -0.74 | $14M | $417K | $13.5M | Jun 3 |
| Q3 2026 · Dec 31 | $65.1M | +3.6% | 64.2% | $8M | $3.6M | — | 0.65 | $18.8M | $732K | $18M | Feb 3 |
| Q2 2026 · Sep 30 | $60.7M | +5.0% | 61.5% | $4.7M | $2.5M | −27.8% | 0.45 | $8.2M | $1.1M | $7.1M | Feb 3 |
| Q1 2026 · Jun 30 | $59.5M | +2.4% | 62.0% | $3.1M | $4.7M | +40.0% | 0.85 | $1.9M | $1M | $884K | Aug 10 |
| Q4 2025 · Mar 31derived | $62.1M | +5.5% | 61.8% | $1.5M | −$7.1M | — | -1.30 | $12.7M | $757K | $11.9M | Jun 3 |
| Q3 2025 · Dec 31 | $62.8M | +17.5% | 63.3% | $5.8M | −$1.7M | −179.2% | -0.31 | $18.1M | $813K | $17.3M | Feb 3 |
| Q2 2025 · Sep 30 | $57.8M | +8.8% | 61.3% | $3.5M | $3.4M | — | 0.63 | $5.3M | $1.8M | $3.5M | Feb 3 |
| Q1 2025 · Jun 30 | $58.2M | — | 64.0% | $5.6M | $3.4M | — | 0.62 | $10.7M | $891K | $9.9M | Feb 3 |
| Q4 2024 · Mar 31derived | $58.9M | — | 62.1% | −$271.3M | −$254.6M | — | -47.26 | $12.9M | $535K | $12.3M | Jun 3 |
| Q3 2024 · Dec 31 | $53.5M | — | 62.5% | −$67K | $2.1M | — | 0.39 | $11.5M | $1.1M | $10.4M | Feb 4 |
| Q2 2024 · Sep 30 | $53.2M | — | 60.4% | −$60K | −$1.2M | — | -0.23 | $9.8M | $634K | $9.1M | Feb 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | $249.1M | 63.5% | $18.5M | $6.7M | 2.7% | 1.21 | $42.8M | $3.3M | $39.6M | — | $3.5M |
| FY2025 · to Mar 31 | $241M | 62.6% | $16.3M | −$2M | -0.8% | -0.36 | $46.8M | $4.2M | $42.6M | — | $3.5M |
| FY2024 · to Mar 31 | $216.2M | 61.6% | −$272.1M | −$254.2M | -117.6% | -47.20 | $44.1M | $2.6M | $41.6M | — | $3.4M |
| FY2023 · to Mar 31 | $219.1M | 61.0% | $3.3M | $930K | 0.4% | 0.17 | $28M | $4.5M | $23.4M | — | $3.4M |
| FY2022 · to Mar 31 | $184.3M | 59.2% | $4.7M | $1.9M | 1.0% | 0.35 | $39.2M | $4.4M | $34.8M | — | $3.3M |
| FY2021 · to Mar 31 | $133.9M | 65.0% | $12.4M | $3.3M | 2.4% | 0.64 | $37.1M | $2M | $35.1M | — | $3.2M |
Every number comes from MESA LABORATORIES INC /CO/'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.